There are several clinical studies available for women with ovarian cancer. For a list of available trials at Mayo Clinic and more details on eligibility criteria, please see: http://www.mayoclinic.org/diseases-conditions/ovarian-cancer/care-at-mayo-clinic/clinical-trials/con-20028096.
There is a clinical trial open at Mayo (MC1464; clinicaltrials.gov identifier: NCT02283658) for women with recurrent ovarian cancer. This is a phase II study in which women with hormone receptor positive ovarian cancer are treated with everolimus and letrozole. As part of the study, an Avatar is made. The Avatar in this study is not used to predict response to other chemotherapies; it is used to better understand the response of the woman’s cancer to the study drugs—everolimus and letrozole. More details on this study can be found at: https://clinicaltrials.gov/ct2/show/NCT02283658?term=MC1464&rank=1.